Paolo Ferrari

I graduated in Molecular Biology at the University of Milan and then moved to the University of Geneva where I obtained my Ph.D. studying the chromatin dynamics and their role in gene expression regulation.

After my doctoral studies, I focused my research activity on the molecular mechanisms that drive the development of breast cancer.

In the last part of my career, before joining Human Technopole, I had the chance to join the Genomics Facility of EPFL in Lausanne, where I trained and developed a strong interest in the NGS and single-cell technologies


  • 11/2023 - Cell Reports Medicine

    RAGE engagement by SARS-CoV-2 enables monocyte infection and underlies COVID-19 severity

    The spread of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has fueled the COVID-19 pandemic with its enduring medical and socioeconomic challenges because of subsequent waves and long-term consequences of great concern. Here, we chart the molecular basis of COVID-19 pathogenesis by analyzing patients’ immune responses at single-cell resolution across disease course and severity. This […]